FdaApplication
NDA 217812
Identifiers
- fda_app_no: NDA217812
Properties
| Property | Value |
|---|---|
| applicant_name | HIKMA PHARMACEUTICALS USA INC |
| application_type | NDA |
| approval_date | 2023-12-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE | 40MG/20ML (2MG/ML) | SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS |
1 product